Login

NON-SUBSCRIBER OPTIONS
FREE TRIAL   |   NEWSSTAND

Inside Drug Pricing - 12/03/2018

Potential Vendors Cautious On Trump Admin’s Medicare Part B Demo

November 30, 2018
Commercial entities that could serve as vendors between manufacturers and providers are a key part of the Trump administration’s proposed Medicare Part B demo, but it is still unclear which, if any, will decide to participate in CMS’ competitive selection process. The administration listed potential vendors as specialty pharmacies, group purchasing organizations, pharmacy benefit managers, distributors, manufacturers and providers in its advance notice of proposed rulemaking announcing the demo. But a lack of detail about reimbursement has left some entities...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.